Opening keynote presentation: The future of cell and gene therapies
Monday, November 2, 2020 9:00 AM to 9:20 AM · 20 min. (Africa/Abidjan)
World Immunotherapy Congress
Keynote sessions: Immunotherapy
Presentation
Information
- Novartis’ vision for B-cell malignancies, with Kymriah and beyond
- Exploring new CAR-T platforms, targets, and disease areas
Stefan Hendriks, SVP, Head of Cell & Gene Therapy, Novartis
Unfortunately, Stefan is not available live to take questions.
